We determined the sequence of a mutant CYP21B gene isolated from a patient with the severe, "salt-wasting" form of congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency. Codon 318 in this gene is changed from CAG, encoding glutamine, to TAG, a nonsense codon. This is predicted to result in a completely nonfunctional enzyme due to premature termination of translation. In addition, when the cloned mutant gene was transfected into mouse VI adrenal cells, the resulting mRNA levels were decreased compared with transfected normal CYP21B genes. This mutation was carried by 3 of 20 unrelated patients with 21-hydroxylase deficiency alleles as determined by hybridization with a specific oligonucleotide probe. This mutation is also seen in the normal CYP21A pseudogone, so that its presence in the abnormal CYP21B gene may be the result of a gene conversion event.
Introduction
Human 2 1-hydroxylase deficiency is the leading cause of impaired cortisol synthesis in congenital adrenal hyperplasia (1) . The incidence of classical 21-hydroxylase deficiency is 1 in 5-10,000 live births; a milder "nonclassical" form of the disease occurs in 0.3% of Caucasians and in 1-3% of European Jews. Deficient cortisol synthesis causes increased secretion of corticotropin (ACTH), resulting in hyperplasia of the adrenal cortex, excessive production of androgens, and consequent virilization. In two-thirds of patients with the classical disease, 2 1-hydroxylase deficiency also impairs aldosterone synthesis, resulting in urinary "salt wasting" with the risk of shock and death in the neonatal period. Steroid 21-hydroxylase deficiency is inherited as an autosomal recessive trait linked to the HLA MHC on chromosome 6. This disorder is caused by a defect in the structural gene that encodes an adrenal microsomal cytochrome P-450, which is specific for steroid 21-hydroxylation (P450c21) (2) . There are two 21 -hydroxylase genes, CYP21A and B (also termed CA21HA and B, or P45OC21A and B), respectively, adjacent to the C4A and C4B genes, which encode the fourth component of serum complement (3, 4) (Fig. 1) . Individuals with homozygous deletions of CYP21A demonstrate normal cortisol synthesizing capacity, whereas homozygous deletion of CYP21B causes 2 1-hydroxylase deficiency. Nucleotide sequence analysis has confirmed that the active enzyme is encoded by the CYP21B gene. The CYP21A gene is 97% homologous to the B gene, but it is rendered nonfunctional by several critical mutations in the coding region, including an 8-bp deletion in exon 3, a l-bp insertion in exon 7, and a nonsense mutation in exon 8 (5, 6) (Fig. 2) .
Deletions of CYP21B account for about one-fourth of classical 21-hydroxylase deficiency alleles (7, 8) . These alleles were presumably generated by unequal crossing-over during meiosis due to the presence of the adjacent CYP21A pseudogene. Two nondeleted mutant CYP21B alleles have been characterized thus far. One (9) contains an amino acid substitution (Ser-269 to Thr) of unknown functional significance and unknown frequency; the other (10) carries a nonconservative amino acid substitution (Ile-172 to Asn) and is found in about 15% ofpatients. This latter mutation is normally present in the CYP21A pseudogene, which suggests that it may have been transferred to the CYP21B gene by a smaller recombinational event, termed a "gene conversion." This paper presents further evidence that gene conversion events are a frequent cause of 21 -hydroxylase deficiency alleles: a nonsense mutation normally present in CYP21A was detected in the CYP21B genes of several patients. In addition to affecting protein synthesis, this mutation may adversely affect mRNA levels.
Methods
Enzymes and related reagents were purchased from International Biotechnologies, Inc. (New Haven, CT) and were used according to the manufacturer's instructions.
Southern blot hybridization. DNA samples were prepared as described ( 11) from peripheral blood leukocytes of 20 unrelated patients with classical 21-hydroxylase deficiency (Table I) . Samples were digested with restriction endonuclease Taq I, subjected to electrophoresis in agarose, and blotted (12) to MSI nylon membranes (Fisher Scientific Co., Springfield, NJ). Blots were hybridized as described (7) to radioactively labeled pC2 1/3c, which contains a nearly full-length cDNA clone encoding human steroid 2 1-hydroxylase (6) . Diminished intensity of the 3.7-kb Taq I band in certain patients, which suggested heterozygous deletion of the CYP21B gene, was confirmed by scanning densitometry and by analysis with additional restriction endonucleases. Many of these patients were previously studied in this manner (10 Sequence analysis was performed by the chain termination method (19) using`S-dATP as described (20) except that reactions were carried out at 370C. In addition to the M13 universal sequencing primer (International Biotechnologies, Inc.), specific 17-bp oligonucleotide primers (synthesized by the Department of Microbiology at Cornell University Medical College) were used, which correspbnded to the normal CYP21B sequence (5, 6). 10 primers were used in each direction to cover the 3. 1-kb length ofthe gene (Fig. 2) . A previously characterized normal CYP21B gene was also analyzed with each primer to eliminate the possibility of artifacts arising from the use of specific primers.
Hybridization studies using oligonucleotides. DNA samples from 20 patients were digested with Taq I and subjected to electrophoresis in 3-mm-thick; horizontal 0.8% agarose gels. Gels were alkalinized, neutralized, and dried as described (21) .
Oligonucleotides were end labeled using [32P]ATP and polynucleotide kinase to a specific activity of I09 dpm/Mg, and purified by electrophoresis in polyacrylamide. Gels were hybridized overnight at 530C with labeled oligonucleotides (4 X 106 dpm/ml) in 0.9 M NaCl, 90 mM Na citrate (pH 7), 0.5% SDS, and 0.2 mg/ml salmon sperm DNA. Gels were washed in 3 M tetramethylammonium chloride as described (22, 23) , with the modification that the first three washes were at room temperature and the fourth was at 630C for 10 min.
Transfection into YJ cells. Cultured Y1 mouse adrenocortical tumor cells were cotransfected as described (24) with pSV2-neo (2 Mg) and plasmids carrying normal or mutant human CYP21B genes (15 Mig). After selection with G418 (Gibco Laboratories, Grand Island, NY)
at 400 Mg/ml, resistant clones were pooled and maintained in selective medium. Analysis of expression of transfected CYP21B genes. The expression of the transfected genes was assessed by RNase protection assays as described (25) . The probe consisted of a 316-bp Pst I-Eco RI fragment of the normal human CYP21B gene, which contained the entire third exon (155 bp), the third intron, and 48 bp from the fourth exon, cloned into pIBI31. A radioactively labeled antisense transcript was synthesized using T7 polymerase (Boehringer Mannheim Diagnostics, Inc., Indianapolis, IN) and [32P]UTP. Total cellular RNA that was prepared (26) from a human adrenal gland or from pools of transfectants was hybridized to the radiolabeled probe for 12 h at 50°C under the described conditions. Single-stranded RNA was then digested with a mixture of RNase A and RNase T1. The protected fragments were resolved by electrophoresis on an 8 M urea, 6% polyacrylamide gel, and the dried gel was autoradiographed.
Results
A nonsense mutation causing 21-hydroxylase deficiency. A partial genomic library of 200,000 clones was prepared from DNA from a patient with salt-wasting 2 1-hydroxylase deficiency. Seven clones were isolated that carried CYP21 genes, of which one carried the single nondeleted CYP2JB gene.
Several mutations were observed in this gene (Fig. 3 ). These included a 3-bp insertion between codons 9 and 10 in exon 1 (which inserts an extra leucine residue into a series of four successive leucines), a silent third-position change in codon 248 (numbering of codons does not include the 3-bp insert) from CTC to CTG, and a change in codon 281 from GTG, encoding valine, to T TG, leucine. A cluster of several mutations was also observed within the second intron (intron b). Most importantly, codon 318 in exon 8 is changed from CAG, encoding glutamine, to TAG, which is a nonsense codon. This is predicted to cause premature termination of translation of the mRNA before the conserved "heme-binding" region of the P450 polypeptide, which results in a completely nonfunctional enzyme. All of these mutations are samples from patients with 2 1-hydroxylase deficiency (Fig. 4) . Because this mutation is normally present in the CYP21A pseudogene, it was expected that DNA from normal individuals would contain a hybridizing Taq I fragment of 3.2 kb, corresponding to the CYP21A genes, but no signal at 3.7 kb, which is the size of the Taq I fragments from the CYP21B genes. In fact, 19 'W"I .111& hybridizing band of 3.2 kb, while 3 of 20 patients (patients C, 0, and P; the mutant gene was isolated from DNA of patient C) carried a 3.7-kb Taq I fragment that hybridized with this probe. These three patients who have CYP2JB genes with the codon 318 mutation suffer from the salt-wasting form of 21-hydroxylase deficiency. They all have a heterozygous deletion of CYP2JB. Two of them carry the HLA-Bw47;DR7 haplotype known to carry such a deletion; no other HLA-B antigen is shared by any of these patients (Table I) .
Expression of human CYP21B genes in transfected YJ cells. To determine if mRNA transcribed from this mutant gene was present in normal amounts, plasmids carrying the normal and mutant CYP2JB genes were transfected into Yl mouse adrenocortical tumor cells. Pools of transfectant clones were prepared to minimize the effect of clonal variation on 21-hydroxylase (CYP21B) expression. RNase protection assays (which are more sensitive than Northern blots) were used to determine steady-state mRNA levels in transfectants. The results (Fig. 5) show that Yl cells transfected with either the normal or the mutant gene contain CYP2JB transcripts, as documented by their protection of a 155-nucleotide fragment (corresponding to all of exon 3) that is identical in size to the fragment protected by authentic human adrenal mRNA. In addition to the protected fragment of 155 nucleotides, these samples also contained a 48-nucleotide fragment protected by sequences contained in exon 4, which was poorly resolved under the gel conditions used (not shown). As previously noted (24) , parental Y1 cells do not express their own 2 1-hydroxylase genes. This technique is only semiquantitative, as evidenced by the substantial variation in mRNA levels in dif- T SW 18 1 18 5 Patients are "salt-wasters" (SW), who are unable to synthesize aldosterone normally, or "simple virilizers" (SV), who are able to synthesize aldosterone. HLA-B and -DR haplotypes are shown. * Patients with a mutation in codon 318. MUTANT -I MUTANT-2 Figure 5 . Levels of 21 (27) .
The results also suggest a mechanism whereby the mutations in the sequenced CYP21B gene have occurred. Relatively small nonreciprocal recombination events, or "gene conversions," could account for identity between the mutations found on the CYP21B gene and on the corresponding positions on the CYP21A pseudogene. In the case ofthe codon 318 nonsense mutation, an independent point mutation cannot be ruled out. The precise borders of the putative gene conversion cannot be firmly established because of the high degree of homology between the CYP21A and B genes; the maximum size, based on the absence of other mutations from CYP21A, would extend from the 3' end ofintron g to codon 355 in exon 8. The two other possible gene conversions in exons of this mutant gene (the 3-bp insertion in exon 1 and the mutations in exon 7 affecting codons 248 and 281) and the cluster of mutations in intron b are separated in CYP21A from the codon 318 mutation by intervening mutations that are not present in the mutant CYP21B gene. Thus, ifthey are gene conversions, they must have been transferred to CYP21B in independent events. The mutations in intron b and the extra leucine resulting from the 3-bp insertion in exon 1 have no obvious functional significance and might exist as polymorphisms of the CYP21B gene in the normal population. The extra leucine is present in P45Oc21 ofmice (28) and cattle (29) and has been documented in a cloned normal CYP21B gene (9) . The codon 281 mutation is associated with a very common nonclassical 21 -hydroxylase deficiency allele (30) and therefore heterozygous carriers of this mutation should also occur frequently in the general population. Thus, the existence ofthese multiple gene conversions in one mutant CYP21B gene is not surprising.
In addition to containing a mutation that prevents synthesis of a functional protein, the steady-state levels of mRNA transcribed from this mutant gene in Yl adrenal cells are substantially decreased from the levels observed when normal CYP21B genes are transfected. This finding might be explained by a difference in the rate ofintegration ofnormal and mutant CYP21B genes into the Yl cell genome or by an additional undetected mutation in the promoter region that affects transcription of the mutant gene. It is more likely that the nonsense mutation itself affects mRNA stability. This may occur because the mRNA downstream of the nonsense mutation does not carry ribosomes and may be more susceptible to nucleases. The same phenomenon has previously been noted in a nonsense mutation, which causes #0-thalassemia (31) , and in the murine 21-hydroxylase pseudogene (28) . It will be necessary to assess the transcriptional activity of the transfected genes in order to definitively answer this question.
While this study has identified 3 out of 20 patients with possible gene conversions causing 21-hydroxylase deficiency, there are 10 other mutations in the CYP21A pseudogene that terminate protein synthesis or change amino acid sequences, and which therefore might result in 2 1-hydroxylase deficiency if they were transferred to the CYP21B gene. Indeed, a mutation in codon 172 which is normally found in the CYP21A gene has been documented in the B genes of three patients with 21-hydroxylase deficiency (10) . Thus, gene conversions might prove to be as common as deletions as a cause of 21 -hydroxylase deficiency alleles.
Humans, mice (32) , and cattle (33) all have two 21-hydroxylase genes, which suggests that the duplication occurred before mammalian speciation. It has been slightly puzzling that, in mice and men, the two 21 -hydroxylase genes are much more homologous to each other than they are to the corresponding gene in the other species. The high frequency of apparent gene conversions provides an explanation for this finding. It is likely that sequences from CYP21B may occasionally be transferred to CYP21A by this mechanism. It should be noted that DNA from patient K in this study (who has a heterozygous deletion of CYP21A) yields no signal at 3.2 kb when probed with the oligonucleotide that corresponds to the codon 318 mutation, although the identical gel displays a strong signal at this position when probed with additional CYP21A-specific oligonucleotides (not shown). This CYP21A gene may thus have reverted to the CYP21B sequence in this region. Gene conversions have also been documented as a factor in the evolution of other cytochrome P450 gene families (34) .
Oligonucleotide hybridization might improve prenatal diagnosis of 21-hydroxylase deficiency. At present, prenatal diagnosis is based on HLA typing of fibroblasts and measurement of hormone levels in amniotic fluid obtained by amniocentesis at about the 16th wk ofgestation (35) , or HLA typing can be performed by Southern blot hybridization using DNA prepared from a chorionic villus sample (36) . Prenatal diagnosis using oligonucleotide probes has two potential advantages over HLA typing: it obviates the need for a DNA sample from the index case and it excludes possible misdiagnosis due to recombinations within the HLA complex. The efficiency of this approach would be improved by prior identification ofthe involved mutations in the parents. Southern blot analysis of several restriction digests using a 2 1-hydroxylase cDNA probe would be necessary to detect deletions and to rule out gene conversions involving the restriction sites used to distinguish the CYP21A and CYP21B genes.
Oligonucleotide hybridization using DNA obtained by chorionic villus biopsy would enable a diagnosis before the differentiation ofthe fetal external genitalia. Virilization ofthe external genitalia in an affected female fetus might be prevented by the administration of glucocorticoids to the mother before this critical time of development (37) . To be practical, this method of prenatal diagnosis will require identification of additional mutations that cause 2 1-hydroxylase deficiency.
